| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6344fe01157f66425d311f760a1e773 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
1989-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f044cad3a31da852c1a1432314e72861 |
| publicationDate |
1990-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H02255097-A |
| titleOfInvention |
Monoclonal antibody nny128 |
| abstract |
PURPOSE:To obtain a monoclonal antibody which is a monoclonal antibody capable recognizing a specific glycopeptide and sufficiently reacting with human intestinal cancer tissues and peripheral parts thereof without reacting with numeral tissues at all. CONSTITUTION:A monoclonal antibody capable of recognizing a glycopeptide having a structure expressed by formula I, II or III (R is N-acetylgalactosamine; A is amino acid residue; B is amino acid sequence). A hybridoma secreting the above-mentioned antibody can be obtained by subjecting splenic cells prepared from a mouse immunized by administering human cancerous cell LS180 into the abdominal cavity and myelomatous cells to cell fusion according to a conventional method and selecting a clone capable of producing an antibody having reactivity with saccharide chains of mucin type glycopeptide previously prepared from the LS180 cells. The above-mentioned hybridoma is named Hybridoma NNY128 and deposited as FERM BP-2330. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019513410-A |
| priorityDate |
1989-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |